LataMed AI Corp. (LMED)
0.48
+0.08
(+19.97%)
USD |
OTCM |
Aug 21, 16:00
LataMed AI Net Income (Quarterly) : -0.0874M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0874M |
| March 31, 2026 | -0.0528M |
| December 31, 2025 | -0.1175M |
| September 30, 2025 | -0.0363M |
| June 30, 2025 | -0.0292M |
| March 31, 2025 | -0.0245M |
| December 31, 2024 | -0.9174M |
| September 30, 2024 | -0.0435M |
| March 31, 2024 | -0.0422M |
| December 31, 2023 | 1.241M |
| September 30, 2023 | -2.938M |
| June 30, 2023 | -0.0189M |
| March 31, 2023 | -0.0177M |
| December 31, 2022 | 0.019M |
| September 30, 2022 | -7.840M |
| June 30, 2022 | -0.02M |
| March 31, 2022 | -0.1113M |
| December 31, 2021 | -0.0351M |
| September 30, 2021 | -0.0678M |
| June 30, 2021 | -0.0639M |
| March 31, 2021 | -0.0975M |
| December 31, 2020 | -14.74M |
| September 30, 2020 | -0.0141M |
| June 30, 2020 | -0.0381M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.0147M |
| December 31, 2019 | -0.7525M |
| September 30, 2019 | -0.0112M |
| June 30, 2019 | -0.0015M |
| March 31, 2019 | -0.0158M |
| June 30, 2018 | -0.0011M |
| March 31, 2018 | -0.0011M |
| March 31, 2016 | -0.041M |
| December 31, 2015 | -0.0255M |
| September 30, 2015 | -2.444M |
| June 30, 2015 | -0.0349M |
| March 31, 2015 | 0.0059M |
| December 31, 2014 | -0.0293M |
| September 30, 2014 | -0.029M |
| June 30, 2014 | -3.776M |
| March 31, 2014 | -0.0307M |
| December 31, 2013 | -0.0355M |
| September 30, 2013 | -0.1685M |
| June 30, 2013 | -0.0107M |
| September 30, 2010 | -0.0314M |
| June 30, 2010 | -0.0407M |
| March 31, 2010 | -0.0286M |
| September 30, 2009 | -0.0059M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| SCWorx Corp. | -0.121M |
| Health Catalyst, Inc. | -40.54M |
| GoodRx Holdings, Inc. | 8.536M |
| Claritev Corp. | -59.23M |
| iSpecimen, Inc. | -1.363M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.0874M |
| EPS Diluted (Quarterly) | -0.0004 |
| Enterprise Value | 87.20M |
| Earnings Yield | -0.31% |
| Normalized Earnings Yield | -0.3125 |